Intrinsic Value of S&P & Nasdaq Contact Us

CDT Equity Inc. CDT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CDT Equity Inc. (CDT) trades at a trailing P/E of 0.0. Trailing earnings yield is 24,480.24%. Graham Number is $16,557.31.

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Trailing Earnings Yield 24,480.24% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 56/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
59/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
33/100
→ Income
GROWTH
100/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — CDT

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA12.5
Per Share Data
EPS (TTM)$1,512.88
Book Value / Share$8,053.66
Revenue / Share$4,586.75
FCF / Share$1,392.94
Yields & Fair Value
Earnings Yield24,480.24%
Dividend Yield0.00%
Graham Number$16,557.31

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2021 -2.0 0.00 348.06 0.00 -
2022 -9,229.1 98.90 -4,470.45 0.00 -
2023 -17,087.9 -3.27 -20,004.47 0.00 -
2024 -9.4 -0.02 -24.66 0.00 -
2025 0.0 0.00 0.00 0.00 157.14%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2021 $-0.05 $0.00 $-3.66M -
2022 $-0.56 $0.00 $-4.89M -
2023 $-0.18 $0.00 $-535K -
2024 $4.80 $922.22M $198.43M 21.5%
2025 $1,477.50 $2.72B $237.52M 8.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message